NeuroscienceExperimental NeurologyPeer-reviewed
Acute treatment with TrkB agonist LM22A-4 confers neuroprotection and preserves myelin integrity in a mouse model of pediatric traumatic brain injury
Jessica L. Fletcher, Larissa K. Dill, Rhiannon J. Wood…·Bridgette D. Semple
This study shows that acute treatment with TrkB agonist LM22A-4 after pediatric TBI reduces tissue damage and preserves myelin integrity, with some behavioral improvements.
51 citationstop 4%